Jerel Davis is a San Francisco-based Investment Professional.

Jerel joined Versant from McKinsey & Company where he was an Associate Principal.  During his six years with McKinsey, he advised healthcare corporations in pharmaceuticals, biotechnology, medical device, and molecular diagnostics.  He has worked in a number of healthcare markets globally including the US, Europe, China, Russia, and India.  Jerel was a post doctoral researcher at Stanford University until 2005 and a researcher at Amgen from 1999-2000.

Jerel is currently a board observer at Anaphore, Flexion, Inception, Metabolex, and Quanticel.

Jerel received a PhD in Biological Sciences from Stanford University where he studied Genomics and Population Genetics.  Jerel earned a BS in Biology and Mathematics from Pepperdine University.